Drug Type Small molecule drug |
Synonyms Acolbifene/prasterone, Dehydroepiandrosterone/Acolbifene, DHEA/Acolbifene + [2] |
Target |
Action agonists |
Mechanism AR agonists(Androgen Receptor agonists), ERs agonists(Estrogen receptors agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC29H31NO4 |
InChIKeyDUYNJNWVGIWJRI-LJAQVGFWSA-N |
CAS Registry182167-02-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hot Flashes | Phase 3 | Canada | 01 Oct 2011 | |
| Vascular Diseases | Phase 3 | Canada | 01 Oct 2011 | |
| Decreased libido | Phase 3 | Canada | - | |
| Hypogonadism | Phase 3 | Canada | - | |
| Breast Cancer | Preclinical | Canada | - |





